LAUSR

Lanthanides are widely codoped in persistent luminescence phosphors (PLPs) to elevate defect concentration and enhance luminescence efficiency. However, the deleterious cross-relaxation between activators and lanthanides inevitably quenches persistent luminescence, particularly in heavily doped phosphors. Herein, we report a core-shell engineering strategy to minimize the unwanted cross-relaxation but retain the charge trapping capacity of heavily doped persistent luminescence phosphors by confining the activators and lanthanides in the core and shell, respectively. As a proof of concept, we prepared a series of codoped ZnGa2O4:Cr, Ln (CD-Ln, Ln = Nd, Eu, Gd, Tb, Dy, Ho, Er, Tm, Yb) and core-shell structured ZnGa2O4:Cr@ZnGa2O4:Ln (CS-Ln) nanoparticles. First-principles investigations suggested that lanthanide doping elevated the electron trap concentration for enhancing persistent luminescence, but energy transfer (ET) from Cr3+ to Ln3+ ions quenched the persistent luminescence. The spatial separation of Cr3+ and Ln3+ ions in the core-shell structured CS-Ln nanoparticles suppressed the ET from Cr3+ to Ln3+. Due to the efficient suppression of deleterious ET, the optimal doping concentration of Ln in CS-Ln was elevated 50 times compared to CD-Ln. Moreover, the persistent luminescence intensity of CS-5%Ln was up to 60 times that of the original ZnGa2O4:Cr. The CS-5%Ln displayed significantly improved signal-to-noise ratios in bioimaging. Further, the CS-Ln was interfaced with the lycopene-producing bacteria Rhodopseudomonas palustris for solar-to-chemical synthesis, and the lycopene productivity was increased by 190%. This work provides a reliable solution to fulfill the potential of lanthanides in enhancing persistent luminescence and can further promote the applications of persistent luminescence phosphors in biomedicine and solar-to-chemical synthesis.